Evidence map›Paper›PMID 38447197›Full record

ArticleInterdisciplinary cardiovascular and thoracic surgery2024

Mitral valve replacement in children: balancing durability and risk with mechanical and bioprosthetic valves.

Joeri Van Puyvelde, Bart Meyns, Filip Rega, Marc Gewillig, Benedicte Eyskens, Ruth Heying, Bjorn Cools, Thomas Salaets, Peter-William Hellings, Bart Meuris

Open access · diamondAbstract read
In one paragraph

Article in Interdisciplinary cardiovascular and thoracic surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Joeri Van PuyveldeDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.ORCID 0000-0003-2003-2029
Bart MeynsDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.ORCID 0000-0002-8110-4009
Filip RegaDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.ORCID 0000-0002-8428-2302
Marc GewilligDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.ORCID 0000-0002-4595-5922
Benedicte EyskensDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.ORCID 0000-0001-5421-0781
Ruth HeyingDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.ORCID 0000-0003-0743-0823
Bjorn CoolsDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Thomas SalaetsDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.ORCID 0000-0002-0971-5147
Peter-William HellingsDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Bart MeurisDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.ORCID 0000-0001-9176-293X
KU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate if there is still a place for bioprosthetic mitral valve replacement in children by comparing the prosthetic durability and transplant-free survival after bioprosthetic and mechanical mitral valve replacement.

methodsWe reviewed all mitral valve replacements in children between 1981 and 2020. Bioprosthetic mitral valve replacement cases were individually matched to mechanical mitral valve replacement cases. The incidence rate of a 2nd replacement was calculated using the cumulative incidence function that considered death or transplantation as a competing risk.

resultsThe median age at implantation was 3.6 years (interquartile range 0.8-7.9) for the bioprosthetic valve cohort (n = 28) and 3 years (interquartile range 1.3-7.8) for the mechanical valve cohort (n = 28). Seven years after bioprosthetic mitral valve replacement, the cumulative incidence of death or transplantation was 17.9% [95% confidence interval (CI) 6.3-34.1] and the cumulative incidence of a 2nd replacement was 63.6% (95% CI 39.9-80.1). Seven years after mechanical mitral valve replacement, the cumulative incidence of death or transplantation was 28.6% (95% CI 13.3-46) and the cumulative incidence of a 2nd replacement was 10.7% (95% CI 2.6-25.5). Fifteen years after mechanical mitral valve replacement, the cumulative incidence of death or transplantation was 33.6% (95% CI 16.2-52.1) and the cumulative incidence of a 2nd replacement was 41.1% (95% CI 18.4-62.7). The cumulative incidence curves for bioprosthetic and mechanical mitral valve replacement were statistically different for a 2nd valve replacement (P < 0.001) but not for death or transplantation (P = 0.33).

conclusionsThere is no difference in transplant-free survival after bioprosthetic and mechanical mitral valve replacement in children. The lifespan of bioprosthetic mitral valves remains limited in children because of structural valve failure due to calcification. After 15 years, 40% of mechanical valves were replaced, primarily because of patient-prosthesis mismatch related to somatic growth.

Indexed as

Bioprosthetic mitral valveCongenitalMechanical mitral valveMitral valve replacementPaediatric

Identifiers

PMID38447197
PMCPMC10948284
OpenAlexW4392501002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.